.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Dani Flinkman

Turku / FI

Turku Bioscience, University Of Turku And Åbo Akademi

Speaker

Wed, Oct 23
Poster presentation
P-III-1023
Investigation of Parkinson's disease heterogeneity and driving factors based on DIA proteomics analysis of patient PBMCs
Human Health Insights (Neurobiology, Cardiovascular, Liver, Kidney etc.)

Further involvements

Wed, Oct 23
Poster presentation
P-III-1023
Investigation of Parkinson's disease heterogeneity and driving factors based on DIA proteomics analysis of patient PBMCs
Human Health Insights (Neurobiology, Cardiovascular, Liver, Kidney etc.)